Acropolis Investment Management, LLC
Position in GILD — Gilead Sciences, Inc.
CIK 1318601
ST. LOUIS, MO
Position in GILD
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$202,902
-$17,581 QoQ
Shares Held
1,606
+1.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#1,910
of 2,266 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Acropolis Investment Management, LLC holds $13,272,644 across 8 Drug Manufacturers - General names. GILD ranks #8 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
20,115 | $5,108,606 | |
| 2 | LLY |
ELI LILLY & Co
|
2,014 | $2,415,652 | |
| 3 | ABBV |
AbbVie Inc.
|
7,039 | $1,771,293 | |
| 4 | MRK |
Merck & Co., Inc.
|
13,768 | $1,769,188 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
17,771 | $1,023,965 | |
| 6 | AMGN |
Amgen Inc
|
1,487 | $538,472 | |
| 7 | PFE |
Pfizer Inc
|
18,379 | $442,566 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
1,606 | $202,902 |
All Filings in GILD
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $202,902 | 1,606 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $220,483 | 1,582 | Shares | Sole | 2026-04-09 | |
| No filing history on record for this holder in this stock. | ||||||